Cadrenal Therapeutics Ownership | Who Owns Cadrenal Therapeutics?
Cadrenal Therapeutics Ownership Summary
Cadrenal Therapeutics is owned by 3.86% institutional investors, 11.93% insiders, and 84.21% retail investors. Vectors research management is the largest institutional shareholder, holding 0.68% of CVKD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.42% of its assets in Cadrenal Therapeutics shares.
CVKD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Cadrenal Therapeutics | 3.86% | 11.93% | 84.21% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vectors research management | 19.84K | 0.68% | $21.42K |
| Geode capital management | 18.96K | 0.65% | $20.47K |
| Jane street group | 13.72K | 0.47% | $14.82K |
| Squarepoint ops | 12.36K | 0.42% | $13.35K |
| Vanguard fiduciary trust | 8.31K | 0.35% | $42.55K |
| Nuveen | 7.24K | 0.25% | $7.89K |
| Ubs group | 5.86K | 0.20% | $6.33K |
| Barclays | 3.89K | 0.13% | $4.20K |
| Tower research capital llc (trc) | 393.00 | 0.02% | $2.01K |
| Quest 10 wealth builders | 380.00 | 0.01% | $410.00 |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vectors research management | 19.84K | 0.01% | $21.42K |
| Quest 10 wealth builders | 380.00 | 0.00% | $410.00 |
| Tower research capital llc (trc) | 393.00 | 0.00% | $2.01K |
| Drw securities | - | - | - |
| Ifp advisors | 30.00 | - | $154.00 |
| Barclays | 3.89K | - | $4.20K |
| Harbour investments | - | - | - |
| Jane street group | 13.72K | - | $14.82K |
| Advisor group | 300.00 | - | $324.00 |
| Destiny wealth partners | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vectors research management | 19.84K | 0.01% | 19.84K |
| Jane street group | 13.72K | - | 13.72K |
| Squarepoint ops | 12.36K | - | 12.36K |
| Vanguard fiduciary trust | 8.31K | - | 8.31K |
| Nuveen | 7.24K | - | 7.24K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Drw securities | - | - | -25.15K |
| Lpl financial | - | - | -13.00K |
| Jpmorgan chase | - | - | -7.50K |
| Blackrock funding, inc. /de | - | - | -5.50K |
| Morgan stanley | 100.00 | - | -980.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vectors research management | 19.84K | 0.01% | 19.84K | $21.42K |
| Jane street group | 13.72K | - | 13.72K | $14.82K |
| Squarepoint ops | 12.36K | - | 12.36K | $13.35K |
| Vanguard fiduciary trust | 8.31K | - | 8.31K | $42.55K |
| Nuveen | 7.24K | - | 7.24K | $7.89K |
Sold Out
| Holder | Change |
|---|---|
| Curio wealth | -1.00 |
| Citigroup | -1.00 |
| Harbour investments | -100.00 |
| Destiny wealth partners | -200.00 |
| Clearstead advisors | -650.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 17 | - | 112,450 | 23.66% | 3 | 27.06% | 10 | 42.86% | 1 | -80.00% |
| Mar 31, 2026 | 17 | -5.56% | 90,938 | -25.15% | 3 | 10.17% | 7 | - | 5 | 150.00% |
| Dec 31, 2025 | 18 | 5.88% | 121,486 | 6.39% | 6 | 19.52% | 7 | -12.50% | 2 | -33.33% |
| Sep 30, 2025 | 17 | 21.43% | 114,193 | 67.08% | 5 | 46.02% | 8 | 14.29% | 3 | - |
| Jun 30, 2025 | 14 | 7.69% | 68,347 | -1.38% | 3 | 24.67% | 7 | -36.36% | 3 | 200.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 33.28K | 1.42% | - |
| Vanguard Morn Total Stk Mkt Idx Investor | 33.28K | 1.07% | - |
| Vanguard MStar Total Stk Mkt Idx Invest | 33.28K | 0.93% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 16.86K | 0.54% | - |
| Abante Quant Value FI | 12.95K | 0.36% | - |
| Fidelity Extended Market Index | 12.24K | 0.34% | - |
| iShares Micro-Cap ETF | 5.23K | 0.17% | - |
| Spartan Extended Market Index Pool F | 2.30K | 0.10% | - |
| Fidelity Series Total Market Index | 2.45K | 0.07% | - |
| NT Ext Equity Mkt Index Fund - NL | 1.55K | 0.07% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Pham Quang X | Chairman and CEO | Sell | $22.42K |
| Jun 26, 2026 | Pham Quang X | Chairman, CEO and Interim CFO | Sell | $27.54K |
| Jun 25, 2026 | Pham Quang X | Chairman, CEO and Interim CFO | Sell | $6.38K |
| Jun 22, 2026 | Pham Quang X | Chairman, CEO and Interim CFO | Sell | $32.54K |
| Jun 23, 2026 | Pham Quang X | Chairman, CEO and Interim CFO | Sell | $7.29K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 21 |
| 2025 Q4 | - | 13 |
| 2025 Q3 | - | 10 |
| 2025 Q1 | - | - |
| 2024 Q2 | - | - |
CVKD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools